Scott C Woller MD

Physician, Intermountain Healthcare Professor of Medicine, University of Utah School of Medicine, Governor, UT Chapter ACP, Tweets my own.

[Scott C Woller MD @SCWollerMD]

Grateful for the opportunity to collaborate at @Research_Inter with colleagues including @DrBenjaminHorne to understand how to best mitigate post-discharge thrombosis risk for hospitalized medical patients at featured in @CleClinicMD : https://t.co/FUiwcp6Jyu @Jess_Intermtn

[Scott C Woller MD @SCWollerMD]

Whether traveling to and from a @Vasculearn board meeting or hiking the Wasatch #wellowcompression socks provide a hug for the 🦵.

[Bloodman @Bloodman]

Great article modeling how screening for iron deficiency is cost effective! https://t.co/PnBIl9xnmx

[Utah Chapter ACP @UT_ACP]

Congratulations to the @ACPIMPhysicians Utah Chapter Scientific Meeting for another amazing Scientific Meeting. Dr. Charlene Dewey, MD MACP from @VUMChealth provides a stellar keynote speech. @UofUInternalMed so well represented along with @Intermountain physician educators!

[Utah Chapter ACP @UT_ACP]

Tremendous poster competition with @UofUInternalMed housestaff and students so well represented! @ACPIMPhysicians.

[Scott C Woller MD @SCWollerMD]

@DrBenjaminHorne @RPTHjournal Terrific to collaborate with you on this @DrBenjaminHorne

[Benjamin Horne 🇺🇸 @DrBenjaminHorne]

Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent venous thromboembolism @SCWollerMD @RPTHjournal https://t.co/8ElqOsUuFq

[Lana Castellucci @LanaCastellucci]

If you are looking for great resources and handouts to share the colleagues, patients, their families, check out @thrombosisday @ThrombosisCan @AnticoagForum @NATFthrombosis @ThrombosisUK @ThrombosisIrL and many, many others!

[ISTH @isth]

We have over 180 registrants so far! Help us reach 200 by the end of the day to spread awareness for #WTDay24!

[Utah Chapter ACP @UT_ACP]

Thank you to the @CDCDirector for sharing key health initiatives with us this morning at the @IMMattersACP Board of Governors meeting!

[Alex Spyropoulos @AlexSpyropoul]

Important New Report: Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Emboli… https://t.co/ysKXMctMqs @PERTConsortium @NATFthrombosis @AnticoagForum @ThrombosisCan @ThrombosisUK @canvector @TromboseLeiden @EuropeanTHA

[University of Utah Department of Internal Medicine @UofUInternalMed]

Congratulations to @AmikoUchidaMD and mentor Kathryn Peterson, MD, MSCI, for their recent study published in @JAMANetwork on eosinophilic gastrointestinal diseases. Explore their findings here: https://t.co/36yMoiHM7c #uofuhealth #internalmedicine #gastroenterology

[Utah Chapter ACP @UT_ACP]

@Intermountain own Dr. Harris Carmichael presents physician attribution work @ACPIMPhysicians!

[Scott C Woller MD @SCWollerMD]

@ACPIMPhysicians @EileenBarrettNM @schunemann_mac Wonderful to see you with my friend Dr. @schunemann_mac and receiving the tremendous recognition!

[Scott C Woller MD @SCWollerMD]

@ACPIMPhysicians @EileenBarrettNM @schunemann_mac Terrific recognition @ACPIMPhysicians and @EileenBarrettNM !

[RPTH @RPTHjournal]

If you're interested in learning more we are holding an RPTH Research Recap on November 8. https://t.co/MXzw5s9L8n

[RPTH @RPTHjournal]

Little is known of health-related quality of life (HRQoL) after venous thromboembolism (#VTE). @wang_huijie @MaryCushmanMD @Erik_Klok_MD @FritsRosendaal @Astridvhv report on change in HRQoL over 1 year after VTE in patients aged ≥70 years.
Read here 👇
https://t.co/pI4J2C6auy

[Geoff Barnes @GBarnesMD]

What is the risk of #VTE recurrence for patients presenting with distal #DVT? It’s low, but meaningful over 5-10 years. Strength of index provoking risk factor was a strong predictor of recurrence. approx 2/3red we’re proximal DVT or PE. #ISTH2023

[Vasculearn Network @Vasculearn]

🚨Paul Dobesh presenting some compelling data for use of Andexanet Alpha at #ISTH2023

Retrospective review comparing 4F-PCC (mean dose 2510units) to Andexanet (~2/3 low dose)
🌟Use if Andexanet Alpha led to a 50% decrease in in-house mortality. (1/3)

[Arthur Allen @AAllenPharmD]

This was a great one! If you missed it check it out on @AnticoagForum website or the new YouTube https://t.co/fIjeVcY4l3

[Sarah Candler @sarahgcandler]

What was that? Chairs of the Councils of Early Career Physicians, Resident/Fellow Members, and Student Members are all women?

Mmmhmmmm that’s what I’m talking about!!
@ACPIMPhysicians #IMProud #IM2023